These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11704757)

  • 1. [Treatment of tinea unguium with terbinafine: an open study comparing twelve weeks and twenty-four weeks of continuous terbinafine therapy, and determination of terbinafine level in the target nails].
    Higashi N
    Nihon Ishinkin Gakkai Zasshi; 2001; 42(4):259-65. PubMed ID: 11704757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic Dermatophytes Survive in Nail Lesions During Oral Terbinafine Treatment for Tinea Unguium.
    Iwanaga T; Ushigami T; Anzawa K; Mochizuki T
    Mycopathologia; 2017 Aug; 182(7-8):673-679. PubMed ID: 28281037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
    Tausch I; Bräutigam M; Weidinger G; Jones TC
    Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V
    Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium.
    Matsumoto T; Tanuma H; Kaneko S; Takasu H; Nishiyama S
    Mycoses; 1995; 38(3-4):135-44. PubMed ID: 7477090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent.
    Goodfield MJ; Rowell NR; Forster RA; Evans EG; Raven A
    Br J Dermatol; 1989 Dec; 121(6):753-7. PubMed ID: 2532927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short therapy for tinea unguium with terbinafine: four different courses of treatment.
    Albanese G; Di Cintio R; Martini C; Nicoletti A
    Mycoses; 1995; 38(5-6):211-4. PubMed ID: 8531933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.
    Smith EB; Stein LF; Fivenson DP; Atillasoy ES
    Int J Dermatol; 2000 Nov; 39(11):861-4. PubMed ID: 11123452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison and complete cure rates of Terbinafine efficacy in affected onychomycotic toenails.
    Shemer A; Sakka N; Baran R; Scher R; Amichai B; Norman L; Farhi R; Magun R; Brazilai A; Daniel R
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):521-6. PubMed ID: 25079781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.